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Clerodendron capitatum (Willd) (family: verbenaceae) is locally named as Gung and used traditionally to treat erectile dysfunction.
Therefore, the current study was designed to investigate the erectogenic properties of C. capitatum. The relaxation eﬀect of this
plant was tested on phenylephrine precontracted rabbit corpus cavernosum smooth muscle (CCSM). The eﬀects of C. capitatum
were also examined on isolated Guinea pig atria alone, in the presence of calcium chloride (Ca2+ channel blocker), atropine
(cholinergic blocker), and glibenclamide (ATP-sensitive K+ channel blocker). These eﬀects were confirmed on isolated rabbit aortic
strips. The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-
nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID50
of 0.161mg/ml (P < .05). In conclusion, our results suggest that C. capitatum possesses a relaxant eﬀect on CCSM, which is
attributable to the inhibition of PDE-5, but not mediated by the release calcium, activation of adrenergic or cholinergic receptors,
or the activation of potassium channels.
1. Introduction
Erectile dysfunction is a serious clinical problem in adult
men. The malfunction of penile erection could be due to
impaired relaxation of the smooth muscle related to the
increase in blood flow into the spaces of the corpus caver-
nosum [1]. Inhibition of cellular enzyme, phosphodiesterase-
5 (PDE-5), reduces cyclic guanylate monophosphate break-
down, promoting vascular relaxation in the corpora cav-
ernosa and penile erection during sexual stimulation [2].
Since several synthetic drugs commonly used in erectile
dysfunction are associated with undesirable side eﬀects, there
is rising interest in discovering new eﬀective drugs. Various
reports on natural products with vasodilating eﬀects on
corpus cavernosum smooth muscle appeared recently [3, 4].
Clerodendron capitatum (Willd) (family: verbenaceae),
locally named as Gung in Sudan, is an indigenous tropical
African plant, which grows fast, erect, well branched and
grows up to 0.5–2m high [5]. In Sudan, the roots of this plant
are used traditionally in the management of male erectile
dysfunction [6, 7]. In Nigeria, this plant is used to treat
diabetes mellitus, obesity, and hypertension [5]. The genus
Clerodendron is reported to demonstrate versatile biological
activities such as antitumorgenic [8, 9], hypoglycemic,
hypolipidemic [10], hepatoprotective activity against CCl4-
induced liver injury in rats [11, 12], anti-inflammatory [13–
15], radical-scavenging activity [12, 16–18], antidiarrhoeal
[19], antinociceptive, and antipyretic eﬀects [14].
No phytochemical investigation was conducted on
C. capitatum to isolate pure compounds. Nevertheless,
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the presence of saponins, alkaloids, flavonoids, glycosides,
and reducing sugars was confirmed by simple qualitative
methods [5]. To the best of our knowledge, there is only one
paper published regarding the phytomedicinal properties of
C. capitatum by Adeneye et al. [5]. Therefore, an extensive
pharmacological investigation is needed to explore the
biological activities of this plant associated with its folk
phytotherapy for erectile dysfunction. Consequently, the
current study was designed to investigate the erectogenic
properties of C. capitatum.
2. Material and Methods
2.1. PlantMaterial. The plantC. capitatumwas collected by a
team from Medicinal and Aromatic Plants Research Institute
(MAPRI), National Center for Research (NCR), Sudan
during their scientific trip to Nuba Mountains, Kordofan
State, Sudan. The plant was identified and authenticated by
Dr. G. E. B. Elgazali, Department of Chemistry, Production
and Classification, MAPRI, NCR. A voucher specimen was
prepared and deposited in the Herbarium of MAPRI.
2.2. Extraction of Plant Material. The roots of the plant
were coarsely air-dried in the shade and kept in clean
plastic container for the work. The powdered roots (300 gm)
of the plant were exhaustively extracted with methanol
using Soxhlet apparatus. The extract was then evaporated
under reduced pressure and kept in a refrigerator for
further biological investigations. The percentage yield of the
powdered roots was 9.67%.
2.2.1. Sample Preparation. Physiological salt solution was
used as a vehicle to dissolve the C. capitatum root extract
freshly prior to addition into the tissue bath, with a
concentration of 10mg/mL. Vehicle when used as control did
not produce any contracting or relaxant eﬀects into all tissues
preparations.
2.3. Animals. Animals were obtained from the Experimental
Animal House (EAH), MAPRI, NCR, Sudan. The animals
were given standard animal feeding and tap water ad libitum.
This study was approved by the Ethics Committee for Animal
Experimentation, EAH, MAPRI, NCR.
2.4. Rabbit Corpus Cavernosum Smooth Muscle Preparation.
Sexually maturemale New ZealandWhite rabbits (4±0.5Kg)
were used. This experiment was carried out following the
method described by Chuang et al. [24]. The animal was
sacrificed, and penectomies were performed to isolate the
corpus cavernosum smooth muscle (CCSM). CCSM strips
were isolated from the enveloping Tunia albuginea in cool
physiological salt solution (PPS). A thread was attached at
each end of the muscle strip, which was mounted in a
25mL water-jacketed tissue bath containing PSS at 37◦C and
bubbled continuously with air. The tissues were equilibrated
for at least 45 minutes and then stretched incrementally
until tissue strips produced the optimal length, which
occurred at forces of 2-3 grams in the unstimulated tissues.
CCSM strips then contracted with phenylephrine (250 µM).
After a peak force was achieved, diﬀerent concentrations of
C. capitatum were added to tissue bath. The responses were
recorded with isometric transducer. Results were expressed
as percentage of phenylephrine-contracted CCSM. Findings
of C. capitatum were compared to sildenafil, a type-5 CGMP
phosphodiesterase inhibitor.
2.5. Guinea Pig Atrium Preparation. Guinea pigs of either
sex (300–500 g) were used in this study. The pericardium
was carefully removed. The atria were separated from the
ventricles carefully by a cutting at the atrioventricular
septum. A thread was attached to the tip of each atrium
and the preparation was mounted on a tissue holder and
transferred to 25mL organ bath filled with aerated Ringer-
lock’s solution maintained at 30◦C. The upper thread was
attached to isometric transducer. To ensure steady prepara-
tion three readings of the spontaneous atrial rate were made
before extract administration. To investigate the mechanism
C. capitatum on atrium atropine, calcium chloride, and
glibenclamide were used.
2.6. Rabbit Aortic Strip. A rabbit of local strain (1.75 ±
0.25 kg) was used. The rabbit was killed by neck dislocation
and exsanguinated. The chest was opened, the internal
viscera were pulled aside, and the aorta was exposed. The
tissue was transferred to a petri dish containing aerated
Kreb’s solution. The aorta was located over a large plastic
canulla, the surrounding fat and connective tissues were
removed, and aorta was cut spirally to produce continuous
strip. A thread was tied to each end of the strip (3-4 cm),
and one end was fixed to tissue holder. The preparation was
transferred to 25mL organ bath filled with aerated Kreb’s
solution maintained at 37◦C. The isometric contractions
were recorded using isometric transducer connected to
oscillographic recorder. The preparation was allowed to
equilibrate under 1.5–2 gm tension for at least 45 minutes.
Before adding the drugs, adrenaline and plant extract were
left in tissue for two minutes.
2.7. Eﬀect of C. capitatum on Phosphodiesterase Type-5.
This experiment was carried out following the method
described by Kelly and Butler [20]. Two mg of the enzyme
PDE-5 (Sigma Aldrih, USA) were dissolved into 20mL
Trizma buﬀer (pH 8.7) maintained at 37◦C. From the
substrate, p-nitrophenyl phenylephosphate (Sigma Aldrih,
USA), 55.84mg were dissolved in 20mL of Trizma buﬀer to
produce 5mMworking solution. The substrate, enzyme, and
plant methanolic extract solution were immersed separately
in a water bath at 37◦C for 10min to equilibrate. The extract
(0.5mL) was mixed with the enzyme solution (1mL) and
incubated in a water bath maintained at 37◦C to allow the
extract to occupy the active site of the enzyme. Mixture
was then transferred to a clean cuvet, and using spec-
trophotometer (Jenway 6305 UV/VIS spectrophotometer)
the absorbance of the mixture (V◦) at 400 nm was red. This
procedure was repeated using diﬀerent concentrations of the
extract. The mixture (Enzyme with diﬀerent concentration
of the extract) was added to the substrate solution (5mM)
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Figure 1: Relaxant eﬀect of the methanol extract of C. capitatum
on phenylephrine (250 µM) precontracted corpus cavernosum strips.
∗Means with diﬀerent alphabets are significantly diﬀerent from the
control.
left to stand for 30 sec, and absorbance of each concentration
was determined (V 1) at the same wavelength.
2.8. Statistical Analysis. All experimental data was expressed
as mean ± SD. Ordinary least squares regression were
performed to calculate the ID50 and dose dependency. Level
of significance was set as P < .05.
3. Results
3.1. Relaxant Eﬀects of C. capitatum Extract on CCSM.
This study investigated the relaxant eﬀects of C. capitatum
extract and sildenafil on corpus cavernosum smooth muscle
(CCSM) preparation, to clarify mechanistically the eﬀect
of this plant in the penile erection. As demonstrated in
Figure 1, addition ofC. capitatum extract caused a significant
(P < .05) concentration-dependent relaxation of CCSM that
had been precontracted with phenylephrine. The maximal
relaxation and the C. capitatum concentration required to
produce 50% relaxation being 67 ± 8% and 4.0mg/gut bath
(25-mL), respectively. Treatment of tissues with sildenafil
(2mg/gut bath; 25-mL) decreased the contractive responses
to phenylephrine, with the maximal relaxation being only
76± 12.5%.
3.2. Influence of C. capitatum Extract on Cardiac Muscle.
C. capitatum extract when added to atrial preparation in
doses of 1, 2, and 4mg/25-mL (gut bath) depressed clearly
(P < .05) the contractility and the rate of isolated atrium
(Figure 2, n = 6). In about 15min, the inhibitory eﬀect
Table 1: The eﬀect of C. capitatum extract on phosphordiesterase-5
in vitro towards p-nitrophenyl phenyl phosphate.
Treatment % of relaxation∗
C. capitatum 0.30mg/mL 75.1a ± 2.7
C. capitatum 0.15mg/mL 43b ± 1.9
C. capitatum 0.075mg/mL 34c ± 2.5
C. capitatum 0.04mg/mL 31d ± 4.9
C. capitatum 0.02mg/mL 15e ± 3.7
Sildenafil 0.10mg/mL 79a ± 13.2
The controls with vehicle did not show any significant eﬀect. Using
ordinary least squares regression, double reciprocal plot was performed for
the enzyme inhibition (1/Extract concentration versus 1/Absorbance) to
calculate the ID50 and dose dependency.
of the extract achieved its maximum. To investigate that
cardiac inhibitory eﬀect, preincubation of a cholinergic
blocker [atropine sulphate, (5 µg/25-mL, gut bath)] failed to
inhibit the relaxant eﬀect of C. capitatum. It is also observed
that simultaneous administration of CaCl2 (450mM) did
not reverse the plant inhibitory eﬀect. Moreover, prior
addition of glibenclamide in a dose of 500 µg/25-mL failed
to overturn the eﬀect of the plant extract. This study showed
that the plant extract was able to induce nonadrenergic-
noncholinergic eﬀects in penile corpus cavernosum. As
cardiac muscles are known to specific sites for PDE type 5,
it could be suggested that the pharmacological eﬀects of C.
capitatum is due to the inhibition of cGMP hydrolysis.
3.3. Eﬀect of C. capitatum Extract on Rabbit Aortic Strip.
To further investigate the nonadrenergic-noncholinergic
relaxant eﬀect of C. capitatum, rabbit aortic strip was used.
C. capitatum, at doses of 1, 2, and 4mg/25-mL (gut bath), did
not produce any pharmacological activities on rabbit aortic
strip (n = 6). Adrenaline achieved the maximal contracture
in two-minute time when added in a dose of 2mg/mL, gut
bath. In the presence of C. capitatum extract at doses of 1,
2, and 4mg/25-mL (gut bath), adrenaline was not blocked.
These results further suggest that the plant extract did not
interfere with activating or blocking the adrenergic receptors.
3.4. Determination of PDE-5 Activity. Table 1 shows the
results of diﬀerent concentrations of C. capitatum on the
in vitro enzymatic hydrolysis of PNPPP using PDE-5.
Using ordinary least squares regression, double reciprocal
plot was performed for the enzyme inhibition (1/Extract
concentration versus 1/Absorbance) to calculate the ID50 and
dose dependency. The enzymatic hydrolysis of PNPPP, when
recorded spectrophotometrically at 400 nm measuring the
appearance of p-nitrophenol (yellowish color), revealed that
the reaction was dose dependent. It is observed that the plant
extract when added to the enzyme (PDE-5) markedly (P <
.05) and dose dependently (r = −0.983, P < .05) decreased
the rate of enzymatic hydrolysis of PNPPP. The calculation
revealed that ID50 of C. capitatum is 0.161±0.08mg/mL (gut
bath) as shown in Table 1.
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Figure 2: Concentration-dependent relaxation of Guinea pig atria induced by C. capitatum. Administration of the extract in a dose of 1, 2,
and 4mg/mL (gut bath) depressed the contractility (a) and the rate (b) of the atria. Administration of glibenclamide (500 µg/25-mL), CaCl2
(450mM/25-mL), and atropine (5 µg/25-mL) did not reverse the depression.
4. Discussion
In the present study, we have investigated the eﬀect of the
methanolic extract of the roots of Clerodendron capitatum
on the relaxation of phenylephrine precontracted rabbit
corpus cavernosum smooth muscle as well as on PDE-5
hydrolytic activity. These inhibitory activities of C. capitatum
in penile corpus cavernosum were also confirmed using
isolated animal tissues such as Guinea pig atria and rabbit
aorta. This research was conducted based on the popular folk
use of C. capitatum as aphrodisiac and neurotonic tonic in
Sudanese traditional medicine.
Cyclic guanosine 3′,5′-monophosphate (cGMP) is an
important second messenger within cells. At the cellular
level, cGMP is synthesized by guanylyl cyclase and degraded
by phosphodiesterases (PDEs). Roles of cGMP and PDEs
are related to many signalling pathways. Therefore, many
physiological functions, that is, cardiac contractility and
smooth muscle relaxation are controlled by PDEs. PDEs
have been classified to 11 families by diﬀerent specificities
and sensitivities to endogenous and exogenous substances
[21–23]. Penile Erection is a hemodynamic event regulated
by smooth muscle relaxation of CCSM after elevation of
cellular cGMP. Elevation of cGMP levels by PDE-5 inhibitors
is rationale for the therapeutic approach for inducing penile
erection in individuals with erectile dysfunction [24].
C. capitatum significantly potentiated the relaxation of
rabbit cavernosal strips. The PDE-5 inhibitor sildenafil
also prolongs the relaxations of cavernosal tissue and
bovine penile arteries. Furthermore, phenylephrine leads to
concentration-dependent relaxations in animal and human
corpus cavernosum that is enhanced by sildenafil [25].
Therefore, our data showing that C. capitatum also caused
marked in the response curves to phenylephrine in the
rabbit corpus cavernosum indicate that these actions are
due to inhibition of PDE5 in the cavernosal tissue [25, 26].
Our data showed also the in vitro enzymatic hydrolysis
of p-nitrophenyl phenylephosphate (PNPPP) by PDE-5
was inhibited significantly by C. capitatum. The hydrolytic
activity was assayed by monitoring the formation of p-
nitrophenol following enzymatic hydrolysis of PNPPP [20,
27, 28]. This experimental approach has been applied
elsewhere for detection of biological activities of some plant
extracts towards PNPPP [29]. The pattern of relaxation
produced by the extract that mimics the eﬀect of sildenafil
coupled with enzyme substrate inhibitory eﬀect of the extract
suggested that phosphodiesterase inhibition was the possible
mode of action of the extract on CCSM. These findings
support the hypothesis that the ultimate accumulation of
cGMP due to inhibition of PDE-5 is the possible cause of
relaxation of CCSM [25].
The inhibition of PDE-5 by C. capitatum pushed us
to carry out in situ experiments on Guinea pig atria and
rabbit aortic strips to verify the mechanism of C. capitatum.
Our results on Guinea pig atria preparation showed that
the relaxant eﬀects of the plant extract were not interfered
with cellular calcium ion mobilization since simultaneous
administration of calcium chloride did not reverse its
inhibitory eﬀect on the myocardial muscle, however, the
nature of the mechanism governing cross-bridge interactions
with thin filaments and the resulting contraction in smooth
muscle is depended on the Ca+2. There is consensus that
activation by neurotransmitter or depolarization involves
myosin light chain phosphorylation by the Ca+2 calmodulin-
dependent kinase, enabling cross-bridge and cycling [24].
The eﬀect of C. capitatum on Guinea pig atria might
not be due to the competitive antagonism for the mus-
carinic acetylcholine receptors [30] since its action was not
reverse by pre-incubation of atropine sulphate. Moreover,
prior addition of glibenclamide, an ATP-sensitive K+ (K+
ATP) channel blocker, failed to reverse the eﬀect of plant.
Our above-mentioned results also showed that the roots
methanolic extract relaxant properties on CCSM were not
due to adrenergic blockage, since it did not antagonize
the stimulant eﬀect of adrenaline on isolated rabbit aortic
strips.
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From the current study, the plant extract showed high
PDEs inhibitory eﬀect in comparison to the standard PDE
inhibitor, sildenafil. The plant also showed potent relaxation
in precontracted rabbit cavernous strips. This pharmaco-
logical eﬀect is suggested to be through the inhibition of
PDE-5 since the eﬀects of the extract did not interfere with
atropine, calcium chloride, and glibenclamide. It could also
be interesting to further isolate and elucidate the structures
of PDEs inhibitor in these extracts.
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